The Dow Jones Industrial Average is trading up Tuesday afternoon with shares of Walgreens Boots and Goldman Sachs delivering the strongest returns for the...
The Dow Jones Industrial Average is trading up Tuesday afternoon with shares of Walgreens Boots and Goldman Sachs delivering the strongest returns for the price-weighted average. The Dow DJIA, +0.28% was most recently trading 91 points, or 0.3%, higher, as shares of Walgreens Boots WBA, +3.22% and Goldman Sachs GS, +2.31% are contributing to the blue-chip gauge's intraday rally. Walgreens Boots's shares have risen $0.74, or 3.5%, while those of Goldman Sachs are up $7.26, or 2.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Goldman Sachs asset and wealth management executive to retire, as others join firmGoldman Sachs Group Inc. executive Laurence Stein is retiring after 27 years at the bank, according to an internal memo seen by MarketWatch. Stein was most...
Read more »
Goldman Sachs discloses short position in Philips after Dutch regulator review By ReutersGoldman Sachs discloses short position in Philips after Dutch regulator review
Read more »
Hedge funds have bailed on the U.S. consumer in a big way, Goldman Sachs data findsHedge funds are betting that the U.S. consumer is in for a difficult ride.
Read more »
Goldman Sachs says this blood cancer treatment stock can gain 70% ahead of planned drug launchAnalyst Corinne Jenkins upgraded the firm to buy from neutral and maintained her price target of $4.
Read more »
Walgreens In Deal With Tech Firm Pearl Health To Enhance Work With Primary Care DoctorsWalgreens has partnered with the technology company Pearl Health to assist primary care doctors with software and services they need in the shift to value-based care.
Read more »
FDA issues warning letter to CVS, Walgreens and others for selling unapproved eye products By ReutersFDA issues warning letter to CVS, Walgreens and others for selling unapproved eye products
Read more »